Recent Articles

Sleepy Johnson & Johnson (JNJ) Stock Could Finally Wake Up

If Johnson & Johnson (JNJ) deals for Actelion, it would be out of character. But it still could be a boon for JNJ stock. More 

Eli Lilly and Co (LLY) Drug Failure Doesn’t Answer the Bigger Question

Eli Lilly (LLY) may be a bargain after today's plunge, but LLY stock won't be a good Alzheimer's bet anytime in the foreseeable future. More 

Trade of the Day: Johnson & Johnson (JNJ) a Healthy Investment

Johnson & Johnson looks ready to push another leg higher, with a JNJ stock price target of around $135. And don't forget the dividends! More 

3 Stocks to Help You Build a Safe Haven from Post-Election Volatility

Stocks have been quite resilient in the wake of Donald Trump's win. But JNJ, T and NKE can offer a safe haven for worried investors. More 

3 Best Healthcare Stocks to Buy Now

The best healthcare stocks to buy now include Ventas, Johnson & Johnson and Gilead Sciences -- recession-proof companies with good dividends. More 

Enhance Your Income Portfolio With These 4 Dividend Growth ETFs

Here's a case for variable exposure these indexes can provide to work along with a diversified income portfolio for safety and income. More 

PFE Stock: Ignore Pfizer Inc.’s Earnings Miss at Your Own Peril

Pfizer missed on earnings, and PFE stock slipped as a result. But even if you don't own Pfizer, you don't want to ignore what's happening there. More